(RTTNews) - Sanofi announced that Beyfortus (nirsevimab) will be broadly available for babies born in Ontario, Quebec, Nunavut, Northwest Territories, and the Yukon this fall. The administration ...

After the fall of communism in 1989, Budapest emerged as one of the most enchanting destinations in central Europe, buzzing with spectacular landmarks, Michelin-starred restaurants, imposing Belle ...

23 October is a bank holiday, however, Hungarians commemorate a rather tragic event, the 1956 Revolution and Freedom Fight. Traditionally, shops close, and people gather outdoors, where ceremonies and ...

French pharmaceutical group Sanofi and US private equity firm Clayton Dubilier & Rice (CD&R) have entered exclusive negotiations regarding the partial takeover of Sanofi subsidiary Opella.

Sanofi’s shares traded 0.2% lower on Monday morning in Paris. The stock has risen about 2% over the past 12 months. Despite the commitments it faces in France, CD&R has been drawn to the Sanofi ...

Sanofi is aiming to sign an agreement this weekend to sell control of its consumer health business to Clayton Dubilier & Rice, following a last-ditch attempt by a rival bidder to derail the deal ...

The new entity focuses on the discovery, design and development of RLTs. Credit: PeopleImages.com – Yuri A/Shutterstock. Sanofi and Orano Group subsidiary Orano Med have announced a partnership to ...

PARIS, Oct 17 (Reuters) - French drugmaker Sanofi (SASY.PA), opens new tab said on Thursday it was "surprised" by a renewed, higher offer for its consumer arm Opella from private equity firm PAI ...

The buyout firm improves its bid by about €200 million CD&R still aims to sign a deal as soon as the coming days PAI Partners has submitted an improved offer for Sanofi ’s consumer health business, ...

A consortium including French private equity firm PAI Partners has raised its offer for Sanofi's consumer health business, Opella, according to sources. The group has revised its bid by €200m ...